ETS transcription factors and prostate cancer: The role of the family prototype ETS-1 (Review)

International Journal of Oncology

Volumn 40, Issue 6, 2012, Pages 1748-1754

  Adler, David ^a   Wernert, Nicolas ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

ETS 1; Prostate cancer; Transcriptional regulation

Indexed keywords

TRANSCRIPTION FACTOR ELF 1; TRANSCRIPTION FACTOR ER81; TRANSCRIPTION FACTOR ETS 1;

ANGIOGENESIS; APOPTOSIS; CANCER GROWTH; CANCER IMMUNOLOGY; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; GENE FUSION; GENE OVEREXPRESSION; GENE REARRANGEMENT; GENE TRANSLOCATION; HUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CARCINOMA; PROTEIN DNA BINDING; PROTEIN EXPRESSION; REVIEW;

EID: 84861763037     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1380     Document Type: Review

References (53)

1. Leprince D, Gegonne A, Coll J, et al: A putative second cellderived oncogene of the avian leukaemia retrovirus E26. Nature 306: 395-397, 1983. (Pubitemid 14242756)
2. Nunn MF, Seeburg PH, Moscovici C and Duesberg PH: Tripartite structure of the avian erythroblastosis virus E26 transforming gene. Nature 306: 391-395, 1983. (Pubitemid 14242755)
3. Watson DK, McWilliams-Smith MJ, Nunn MF, Duesberg PH, O'Brien SJ and Papas TS: The ets sequence from the transforming gene of avian erythroblastosis virus, E26, has unique domains on human chromosomes 11 and 21: both loci are transcriptionally active. Proc Natl Acad Sci USA 82: 7294-7298, 1985. (Pubitemid 16193728)
4. Hahne JC, Okuducu AF, Sahin A, Fafeur V, Kiriakidis S and Wernert N: The transcription factor ETS-1: its role in tumour development and strategies for its inhibition. Mini RevMed Chem 8: 1095-1105, 2008.
5. Dittmer J: The biology of the Ets1 proto-oncogene. Mol Cancer 2: 29, 2003.
6. Vandenbunder B, Pardanaud L, Jaffredo T, Mirabel MA and Stehelin D: Complementary patterns of expression of c-ets 1, c-myb and c-myc in the blood-forming system of the chick embryo. Development 107: 265-274, 1989. (Pubitemid 19283401)
7. Wernert N, Raes MB, Lassalle P, et al: c-ets1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. Am J Pathol 140: 119-127, 1992.
8. Pourtier-Manzanedo A, Vercamer C, van Belle E, Mattot V, Mouquet F and Vandenbunder B: Expression of an Ets-1 dominant-negative mutant perturbs normal and tumor angiogenesis in a mouse ear model. Oncogene 22: 1795-1806, 2003. (Pubitemid 36513139)
9. Adam M, Schmidt D, Wardelmann E, Wernert N and Albers P: Angiogenetic protooncogene ets-1 induced neovascularization is involved in the metastatic process of testicular germ cell tumors. Eur Urol 44: 329-336, 2003. (Pubitemid 37051701)
10. Behrens P, Rothe M, Wellmann A, Krischler J and Wernert N: The Ets-1 transcription factor is up-regulated together with MMP 1 and MMP 9 in the stroma of pre-invasive breast cancer. J Pathol 194: 43-50, 2001.
11. Behrens P, Mathiak M, Mangold E, et al: Stromal expression of invasion-promoting, matrix-degrading proteases MMP-1 and -9 and the Ets 1 transcription factor in HNPCC carcinomas and sporadic colorectal cancers. Int J Cancer 107: 183-188, 2003. (Pubitemid 37152895)
12. Alipov G, Nakayama T, Ito M, et al: Overexpression of Ets-1 proto-oncogene in latent and clinical prostatic carcinomas. Histopathology 46: 202-208, 2005. (Pubitemid 40293019)
13. Hahne JC, Kummer S, Heukamp LC, et al: Regulation of protein tyrosine kinases in tumour cells by the transcription factor Ets-1. Int J Oncol 35: 989-996, 2009.
14. Wernert N, Stanjek A, Kiriakidis S, et al: Inhibition of angiogenesis in vivo by ets-1 antisense oligonucleotides-inhibition of Ets-1 transcription factor expression by the antibiotic fumagillin. Angew Chem Int Ed Engl 38: 3228-3231, 1999. (Pubitemid 29533905)
15. Wernert N, Gilles F, Fafeur V, et al: Stromal expression of c-Ets1 transcription factor correlates with tumor invasion. Cancer Res 54: 5683-5688, 1994. (Pubitemid 24346267)
16. Laudet V, Niel C, Duterque-Coquillaud M, Leprince D and Stehelin D: Evolution of the ets gene family. Biochem Biophys Res Commun 190: 8-14, 1993. (Pubitemid 23227279)
17. Macleod K, Leprince D and Stehelin D: The ets gene family. Trends Biochem Sci 17: 251-256, 1992.
18. Laudet V, Hanni C, Stehelin D and Duterque-Coquillaud M: Molecular phylogeny of the ETS gene family. Oncogene 18: 1351-1359, 1999. (Pubitemid 29094887)
19. Wasylyk B, Hahn SL and Giovane A: The Ets family of transcription factors. Eur J Biochem/FEBS 211: 7-18, 1993.
20. Hollenhorst PC, Shah AA, Hopkins C and Graves BJ: Genomewide analyses reveal properties of redundant and specific promoter occupancy within the ETS gene family. Genes Dev 21: 1882-1894, 2007. (Pubitemid 47204928)
21. Wei G, Srinivasan R, Cantemir-Stone CZ, et al: Ets1 and Ets2 are required for endothelial cell survival during embryonic angiogenesis. Blood 114: 1123-1130, 2009.
22. Wei GH, Badis G, Berger MF, et al: Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo. EMBO J 29: 2147-2160, 2010.
23. Hollenhorst PC, Jones DA and Graves BJ: Expression profiles frame the promoter specificity dilemma of the ETS family of transcription factors. Nucleic Acids Res 32: 5693-5702, 2004. (Pubitemid 39545685)
24. Oikawa T: ETS transcription factors: possible targets for cancer therapy. Cancer Sci 95: 626-633, 2004.
25. Hashiya N, Jo N, Aoki M, et al: In vivo evidence of angiogenesis induced by transcription factor Ets-1: Ets-1 is located upstream of angiogenesis cascade. Circulation 109: 3035-3041, 2004. (Pubitemid 38811459)
26. Rothhammer T, Hahne JC, Florin A, et al: The Ets-1 transcription factor is involved in the development and invasion of malignant melanoma. Cell Mol Life Sci 61: 118-128, 2004. (Pubitemid 38121905)
27. Hahne JC, Okuducu AF, Kaminski A, Florin A, Soncin F and Wernert N: Ets-1 expression promotes epithelial cell transformation by inducing migration, invasion and anchorage-independent growth. Oncogene 24: 5384-5388, 2005. (Pubitemid 43080108)
28. Sahin A, Vercamer C, Kaminski A, et al: Dominant-negative inhibition of Ets 1 suppresses tumor growth, invasion and migration in rat C6 glioma cells and reveals differentially expressed Ets 1 target genes. Int J Oncol 34: 377-389, 2009.
29. Shaikhibrahim Z, Langer B, Lindstrot A, et al: Ets-1 is implicated in the regulation of androgen co-regulator FHL2 and reveals specificity for migration, but not invasion, of PC3 prostate cancer cells. Oncol Rep 25: 1125-1129, 2011.
30. Tomlins SA, Rhodes DR, Perner S, et al: Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310: 644-648, 2005. (Pubitemid 41528150)
31. Rubin MA, Maher CA and Chinnaiyan AM: Common gene rearrangements in prostate cancer. J Clin Oncol 29: 3659-3668, 2011.
32. Kumar-Sinha C, Tomlins SA and Chinnaiyan AM: Recurrent gene fusions in prostate cancer. Nat Rev 8: 497-511, 2008.
33. Tomlins SA, Laxman B, Dhanasekaran SM, et al: Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature 448: 595-599, 2007. (Pubitemid 47206938)
34. Carver BS, Tran J, Chen Z, et al: ETS rearrangements and prostate cancer initiation. Nature 457: E1-E3, 2009.
35. Joshua AM, Evans A, van der Kwast T, et al: Prostatic preneoplasia and beyond. Biochim Biophys Acta 1785: 156-181, 2008.
36. Mehra R, Tomlins SA, Yu J, et al: Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer. Cancer Res 68: 3584-3590, 2008.
37. Perner S, Svensson MA, Hossain RR, et al: ERG rearrangement metastasis patterns in locally advanced prostate cancer. Urology 75: 762-767, 2010.
38. Perner S, Demichelis F, Beroukhim R, et al: TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer. Cancer Res 66: 8337-8341, 2006. (Pubitemid 44449140)
39. Perner S, Mosquera JM, Demichelis F, et al: TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion. Am J Surg Pathol 31: 882-888, 2007. (Pubitemid 47165141)
40. Sun C, Dobi A, Mohamed A, et al: TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation. Oncogene 27: 5348-5353, 2008.
41. Watson KD, Turner DP, Scheiber MN, Findlay VJ and Watson PM III: ETS transcription factor expression and conversion during prostate and breast cancer progression. Open Cancer J 3: 24-39, 2010.
42. Hollenhorst PC, Paul L, Ferris MW and Graves BJ: The ETS gene ETV4 is required for anchorage-independent growth and a cell proliferation gene expression program in PC3 prostate cells. Genes Cancer 1: 1044-1052, 2011.
43. Helgeson BE, Tomlins SA, Shah N, et al: Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer. Cancer Res 68: 73-80, 2008. (Pubitemid 351380107)
44. Cai C, Hsieh CL, Omwancha J, et al: ETV1 is a novel androgen receptor-regulated gene that mediates prostate cancer cell invasion. Mol Endocrinol 21: 1835-1846, 2007. (Pubitemid 47173795)
45. Shaikhibrahim Z, Lindstrot A, Langer B, Buettner R and Wernert N: Differential expression of ETS family members in prostate cancer tissues and androgen-sensitive and insensitive prostate cancer cell lines. Int J Mol Med 28: 89-93, 2011.
46. Shaikhibrahim Z, Lindstrot A, Buettner R and Wernert N: Analysis of laser-microdissected prostate cancer tissues reveals potential tumor markers. Int J Mol Med 28: 605-611, 2011.
47. Park C, Lee I and Kang WK: Influence of small interfering RNA corresponding to ets homologous factor on senescenceassociated modulation of prostate carcinogenesis. Mol Cancer Ther 5: 3191-3196, 2006. (Pubitemid 46092062)
48. Sementchenko VI, Schweinfest CW, Papas TS and Watson DK: ETS2 function is required to maintain the transformed state of human prostate cancer cells. Oncogene 17: 2883-2888, 1998. (Pubitemid 29010058)
49. Carbone GM, Napoli S, Valentini A, Cavalli F, Watson DK and Catapano CV: Triplex DNA-mediated downregulation of Ets2 expression results in growth inhibition and apoptosis in human prostate cancer cells. Nucleic Acids Res 32: 4358-4367, 2004. (Pubitemid 39232308)
50. Shaikhibrahim Z, Lindstrot A, Langer B, Buettner R and Wernert N: Comprehensive gene expression microarray analysis of Ets-1 blockade in PC3 prostate cancer cells and correlations with prostate cancer tissues: Insights into genes involved in the metastatic cascade. Int J Mol Med 27: 811-819, 2011.
51. Gallant S and Gilkeson G: ETS transcription factors and regulation of immunity. Arch Immunol Ther Exp (Warsz) 54: 149-163, 2006. (Pubitemid 44257335)
52. Shaikhibrahim Z, Lindstrot A, Ellinger J, Rogenhofer S, Buettner R and Wernert N: Identification of immunity-related genes in prostate cancer and potential role of the ETS family of transcription factors in their regulation. Int J Mol Med 28: 799-807, 2011.
53. Shaikhibrahim Z, Lindstrot A, Buettner R and Wernert N: Regulation of prostate cancer immunity-related genes in PC3 prostate cancer cells by ETS-1 Oncol Lett: December 2, 2011 doi: 10.3892/ol.2011.509.